Future strategies involving immune checkpoint inhibitors in advanced urothelial carcinoma

G Grisay, J Pierrard, C Confente, E Seront - Current Treatment Options in …, 2021 - Springer
Opinion statement Immune checkpoint inhibitors have importantly improved the outcome of
patients with urothelial carcinoma. Different immune checkpoint inhibitors are currently …
被引用次数：7 相关文章

Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

G Grisay, J Pierrard, C Confente… - … treatment options in …, 2020 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors have importantly improved the outcome of patients with
urothelial carcinoma. Different immune checkpoint inhibitors are currently approved and …

Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.

G Grisay, J Pierrard, C Confente… - Current Treatment Options …, 2020 - europepmc.org
Immune checkpoint inhibitors have importantly improved the outcome of patients with
urothelial carcinoma. Different immune checkpoint inhibitors are currently approved and …